Active · per the CBE, 17 September 2026

M13 ALimed

BE0793968160

Rechtspersoon Private limited company 1 establishment

Rue du Tilleul(S.-J.-G.) 13, 1370 Jodoigne

Active for

3 year, 9 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Tight liquidity NBB

    Cash and receivables cover 48 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

M13 ALimed from Jodoigne, company number BE0793968160, closed financial year 2025 with a result of € 60,286 after tax. For that financial year M13 ALimed recorded a gross margin of € 113,023 and equity of € 9,395. Compared with financial year 2024, the result moved from € 60,654 to € 60,286. The company is profitable. The buffer shrank hard: equity is 91 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 29, 2026.

What it is worth Shrank hard

€ 9,395

▼ 91% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 60,286

▼ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 20,301

▼ 76% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 157,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 53,282

▲ 101% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go

€ 92,689

▼ 17% vs 2024

€ 24,558 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 52

▼ 95% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,945

▼ 64% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € -2,493 € 75,379 € 115,794 € 113,023 ▼ 2%
Profit after taxes € -2,496 € 42,951 € 60,654 € 60,286 ▼ 1%
Equity € 2,504 € 45,455 € 106,109 € 9,395 ▼ 91%
Total debts € 348 € 147,003 € 127,157 € 124,484 ▼ 2%
Cash € 2,852 € 61,276 € 86,161 € 20,301 ▼ 76%
Retained profit € -2,496 € 40,455 € 101,109 € 4,395 ▼ 96%
Dividend € 0 € 0 € 0 € 157,000
Bank debt € 0 € 131,360 € 111,968 € 92,689 ▼ 17%
Balance sheet total € 2,852 € 192,458 € 233,266 € 133,879 ▼ 43%

Key figures of M13 ALimed, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to M13 ALimed?

What happened at M13 ALimed in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 60,286 (▼ 1% vs 2024). Source: NBB ↗
  • New establishment in Jodoigne. KBO
  • Start of the company according to the CBE. KBO

In short

From € 2,496 loss in 2022 to € 60,286 profit in 2025.

Paid € 50,341 in corporate taxes since 2022.

Best year ever: 2024, with € 60,654 profit.

Paid out € 157,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at M13 ALimed? We notify you, reason included.

Follow M13 ALimed

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

  1. Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
  2. We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
  3. In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Yes, I want that
See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies
  • De Lijn 8 June 2026 New annual account 2025

    filed on 8 June 2026

    What was left

    € 20 k ▼ 91%

    Money in the bank

    € 178 k ▼ 98%

    Open the dossier →

  • NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
  • bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Tilleul(S.-J.-G.) 13

1370 Jodoigne

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0793.968.160
VAT number
BE 0793.968.160
Registered office
Rue du Tilleul(S.-J.-G.) 13, 1370 Jodoigne
Names & denominations
M13 ALimed
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
25 November 2022
Peppol
Active · Active since 9 Dec 2025
View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the address of M13 ALimed?
The registered office of M13 ALimed is located at Rue du Tilleul(S.-J.-G.) 13, 1370 Jodoigne.
Is M13 ALimed still active?
Yes. According to the CBE (17 September 2026) M13 ALimed is active, legal situation “Normale toestand”, started on 25 November 2022.
Is M13 ALimed registered on Peppol?
Yes, M13 ALimed is registered on the Peppol network with ID 0208:0793968160.
What is the enterprise number of M13 ALimed?
The enterprise number of M13 ALimed is BE0793968160.
When was M13 ALimed founded?
M13 ALimed was founded on 25 November 2022.
Is M13 ALimed a reliable company?
Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 November 2022; 4 annual accounts filed, latest fiscal year 2025.